Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly

Age

Volumn 34, Issue 1, 2012, Pages 133-143

  Lahtinen, Sampo J ^a   Forssten, Sofia ^a   Aakko, Juhani ^b   Granlund, Linda ^c   Rautonen, Nina ^a   Salminen, Seppo ^b   Viitanen, Matti ^b   Ouwehand, Arthur C ^a  

^a Danisco Bioactives Health and Nutrition   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c Mills DA   (Norway)

Author keywords

Cheese; Clostridium difficile; Elderly; Gut microbiota; Probiotics

Indexed keywords

BETA DEFENSIN; BIOLOGICAL MARKER; CALGRANULIN; IMMUNOGLOBULIN A ANTIBODY; PROBIOTIC AGENT;

AGED; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL SURVIVAL; CHEESE; CLINICAL ASSESSMENT; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENTERITIS; FECES ANALYSIS; FECES LEVEL; FECES MICROFLORA; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOOD; FOOD ANALYSIS; FOOD INTAKE; GASTROINTESTINAL TRANSIT; HUMAN; HUMAN EXPERIMENT; IMMUNOGLOBULIN BLOOD LEVEL; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE FUNCTION; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; NORMAL HUMAN; OUTCOME ASSESSMENT; POPULATION RESEARCH; PROBIOTIC CHEESE; AGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONSUMER; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; FECES; IMMUNOLOGY; INTESTINE; ISOLATION AND PURIFICATION; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AGING; CHEESE; CLOSTRIDIUM DIFFICILE; COLONY COUNT, MICROBIAL; CONSUMER SATISFACTION; CROSS-OVER STUDIES; FECES; HUMANS; INTESTINES; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; TREATMENT OUTCOME;

EID: 84862338872     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-011-9208-6     Document Type: Article

References (38)

1. Amati L, Passeri ME, Selicato F, Mastronardi ML, Penna A, Jirillo E, Covelli V (2006) New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease. Immunopharmacol Immunotoxicol 28:665-681
2. Bartosch S, Fite A, Macfarlane GT, McMurdo ME (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70:3575-3581
3. Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkilä J, Monti D, Satokari R, Franceschi C, Brigidi P, de Vos W (2010) Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 5:e10667
4. Buck BL, Altermann E, Svingerud T, Klaenhammer TR (2005) Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM. Appl Environ Microbiol 71:8344-8351
5. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, Stanton C, van Sinderen D, O'Connor M, Harnedy N, O'Connor K, Henry C, O'Mahony D, Fitzgerald AP, Shanahan F, Twomey C, Hill C, Ross RP, O'Toole PW (2010) Microbes and Health Sackler Colloquium: composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA. doi: 10.1073/pnas.1000097107
6. Derrien M, Collado MC, Ben Amor K, Salminen S, de Vos WM (2008) The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol 74:1646-1648
7. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308:1635-1638
8. FAO/WHO (2002) Guidelines for the evaluation of probiotics in food. Joint FAO/WHO working group report on drafting for the evaluation of probiotics in food. London, Ontario, Canada
9. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128:92-105
10. Fujihashi K, Kiyono H (2009) Mucosal immunosenescence: new developments and vaccines to control infectious diseases. Trends Immunol 30:334-343
11. Furet JP, Quenee P, Tailliez P (2004) Molecular quantification of lactic acid bacteria in fermented milk products using real-time quantitative PCR. Int J Food Microbiol 97:197-207
12. Gavini F, Cayuela C, Antoine JM, Lecoq C, Lefebvre B, Membre JM, Neut C (2001) Differences in the distribution of bifidobacterial and enterococcal species in human faecal microflora of three different (children, adults, elderly) age groups. Microb Ecol Health Dis 13:40-45
13. Gaya DR, Mackenzie JF (2002) Faecal calprotectin: a bright future for assessing disease activity in Crohn's disease. QJM Int J Med 95:557-558
14. Gill HS, Rutherfurd KJ (2001) Probiotic supplementation to enhance natural immunity in the elderly: effects of a newly characterized immunostimulatory strain Lactobacillus rhamnosus HN001 (DR20™) on leucocyte phagocytosis. Nutr Res 21:183-189
15. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74:833-839
16. Gilliland SE, Speck ML, Nauyok GF Jr, Giesbrecth FG (2010) Influence of consuming nonfermented milk containing Lactobacillus acidophilus on fecal flora of healthy males. J Dairy Sci 61:1-10
17. Gopal PK, Prasad J, Smart J, Gill HS (2001) In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int J Food Microbiol 67:207-216
18. Hopkins MJ, Macfarlane GT (2002) Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51:448-454
19. Hopkins MJ, Sharp R, Macfarlane GT (2001) Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16 S rRNA abundance, and community cellular fatty acid profiles. Gut 48:198-205
20. Ibrahim F, Ruvio S, Granlund L, Salminen S, Viitanen M, Ouwehand AC (2010) Probiotics and immunosenescence: cheese as a carrier. FEMS Immunol Med Microbiol 59:53-59
21. Kalliomäki M, Collado MC, Salminen S, Isolauri E (2008) Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 87:534-538
22. Kapel N, Benahmed N, Morali A, Svahn J, Canioni D, Goulet O, Ruemmele FM (2009) Fecal beta-defensin-2 in children with inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 48:117-120
23. Lahtinen SJ, Tammela L, Korpela J, Parhiala R, Ahokoski H, Mykkanen H, Salminen SJ (2009) Probiotics modulate the Bifidobacterium microbiota of elderly nursing home residents. Age (Dordr) 31:59-66
24. Mäkeläinen H, Forssten S, Olli K, Granlund L, Rautonen N, Ouwehand AC (2009) Probiotic lactobacilli in a semi-soft cheese survive in the simulated human gastrointestinal tract. Int Dairy J 19:675-683
25. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft HJ, Dore J, Blaut M (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72:1027-1033
26. Ouwehand AC, Bergsma N, Parhiala R, Lahtinen S, Gueimonde M, Finne-Soveri H, Strandberg T, Pitkälä K, Salminen S (2008) Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol Med Microbiol 53:18-25
27. Ouwehand AC, Tiihonen K, Saarinen M, Putaala H, Rautonen N (2009) Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr 101:375
28. Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, Lord JM, Shaw AC (2009) Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 30:325-333
29. Peuranen S, Tiihonen K, Apajalahti J, Kettunen A, Saarinen M, Rautonen N (2004) Combination of polydextrose and lactitol affects microbial ecosystem and immune responses in rat gastrointestinal tract. Br J Nutr 91:905-914
30. Plummer S, Weaver MA, Harris JC, Dee P, Hunter J (2004) Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 7:59-62
31. Rinttilä T, Kassinen A, Malinen E, Krogius L, Palva A (2004) Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97:1166-1177
32. Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE (2002) Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 23:696-703
33. Song Y, Liu C, Finegold SM (2004) Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 70:6459-6465
34. Sui J, Leighton S, Busta F, Brady L (2002) 16 S ribosomal DNA analysis of the faecal lactobacilli composition of human subjects consuming a probiotic strain Lactobacillus acidophilus NCFM. J Appl Microbiol 93:907-912
35. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK (2000) Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 66:2578-2588
36. Tiihonen K, Tynkkynen S, Ouwehand A, Ahlroos T, Rautonen N (2008) The effect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointestinal microbiology and immunology. Br J Nutr 100:130-137
37. Varcoe J, Zook C, Sui J, Leighton S, Busta F, Brady L (2002) Variable response to exogenous Lactobacillus acidophilus NCFM consumed in different delivery vehicles. J Appl Microbiol 93:900-906
38. Woodmansey EJ, McMurdo ME, Macfarlane GT, Macfarlane S (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70:6113-6122